Surgery Partners, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US86881A1007
USD
12.05
0.07 (0.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
885.00
821.50
826.20
776.00
864.40
770.40
762.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
885.00
821.50
826.20
776.00
864.40
770.40
762.10
Raw Material Cost
732.70
665.70
670.90
650.40
664.70
643.10
617.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
254.40
242.80
235.20
238.60
240.70
228.40
223.20
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
66.20
73.30
66.60
73.20
65.60
64.80
66.30
Selling and Distribution Expenses
23.70
22.40
36.10
36.00
36.00
29.20
40.30
Other Expenses
-32.06
-31.61
-30.18
-31.18
-30.63
-29.32
-28.95
Total Expenditure (Excl Depreciation)
756.40
688.10
707.00
686.40
700.70
672.30
658.00
Operating Profit (PBDIT) excl Other Income
128.6
133.4
119.2
89.60000000000001
163.70000000000002
98.10000000000001
104.1
Other Income
-1.30
-10.30
9.30
-0.80
10.10
7.50
20.40
Operating Profit (PBDIT)
187.20
162.60
168.80
125.10
207.70
155.80
159.30
Interest
66.20
73.30
66.60
73.20
65.60
64.80
66.30
Exceptional Items
-18.50
-19.00
-18.10
-15.90
-34.00
-29.90
-24.90
Gross Profit (PBDT)
152.30
155.80
155.30
125.60
199.70
127.30
144.40
Depreciation
59.90
39.50
40.30
36.30
33.90
50.20
34.80
Profit Before Tax
42.60
30.80
43.80
-0.30
74.20
10.90
33.30
Tax
13.60
5.50
-1.10
0.00
120.80
4.50
4.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-15.00
-22.70
-2.50
-37.70
-108.50
-31.70
-15.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-15.00
-22.70
-2.50
-37.70
-108.50
-31.70
-15.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
44.00
48.00
47.40
37.40
61.90
38.10
43.90
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.00
25.30
44.90
-0.30
-46.60
6.40
28.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,712.90
1,729.50
1,748.30
1,740.40
1,789.70
1,896.50
1,952.40
Earnings per share (EPS)
-0.12
-0.18
-0.02
-0.3
-0.86
-0.25
-0.12
Diluted Earnings per share
-0.12
-0.18
-0.02
-0.3
-0.86
-0.25
-0.12
Operating Profit Margin (Excl OI)
14.53%
16.24%
14.43%
11.55%
18.94%
12.73%
13.66%
Gross Profit Margin
11.58%
8.56%
10.18%
4.64%
12.51%
7.93%
8.94%
PAT Margin
-1.69%
-2.76%
-0.3%
-4.86%
-12.55%
-4.11%
-2.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 2.38% vs 17.54% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 162.23% vs -199.79% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -4.61% vs 14.42% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 0.91% vs 9.15% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Surgery Partners, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
885.00
5,527.00
-4,642.00
-83.99%
Other Operating Income
0.00
0.00
0.00
Total Operating income
885.00
5,527.00
-4,642.00
-83.99%
Raw Material Cost
732.70
4,658.00
-3,925.30
-84.27%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
254.40
2,222.00
-1,967.60
-88.55%
Power Cost
0
0
0.00
Manufacturing Expenses
66.20
205.00
-138.80
-67.71%
Selling and Distribution Expenses
23.70
0.00
23.70
Other Expenses
-32.06
-242.70
210.64
86.79%
Total Expenditure (Excl Depreciation)
756.40
4,658.00
-3,901.60
-83.76%
Operating Profit (PBDIT) excl Other Income
128.60
869.00
-740.40
-85.20%
Other Income
-1.30
115.00
-116.30
-101.13%
Operating Profit (PBDIT)
187.20
1,215.00
-1,027.80
-84.59%
Interest
66.20
205.00
-138.80
-67.71%
Exceptional Items
-18.50
-98.00
79.50
81.12%
Gross Profit (PBDT)
152.30
869.00
-716.70
-82.47%
Depreciation
59.90
231.00
-171.10
-74.07%
Profit Before Tax
42.60
681.00
-638.40
-93.74%
Tax
13.60
37.00
-23.40
-63.24%
Provisions and contingencies
0
0
0.00
Profit After Tax
-15.00
371.00
-386.00
-104.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-15.00
371.00
-386.00
-104.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
44.00
273.00
-229.00
-83.88%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.00
644.00
-615.00
-95.50%
Equity Capital
0
0
0.00
Face Value
0.01
0.05
0.00
Reserves
1,712.90
4,220.00
-2,507.10
-59.41%
Earnings per share (EPS)
-0.12
4.22
-4.34
-102.84%
Diluted Earnings per share
-0.12
4.22
-4.34
-102.84%
Operating Profit Margin (Excl OI)
14.53%
15.72%
0.00
-1.19%
Gross Profit Margin
11.58%
16.50%
0.00
-4.92%
PAT Margin
-1.69%
6.71%
0.00
-8.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 88.50 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.73% vs -0.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 2.38% vs 17.54% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.62% vs -43.65% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 162.23% vs -199.79% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.85 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 9.02% vs 8.40% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -4.61% vs 14.42% in Dec 2024

Quarterly - Interest
Interest 6.62 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -9.69% vs 10.06% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.91% vs 9.15% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.53%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024